Photopheresis Product Market - Global Forecast 2025-2032

The photopheresis product market is experiencing robust, sustained growth as healthcare systems globally integrate advanced immunotherapy approaches. Senior healthcare executives are positioning photopheresis as a core strategy within modern, patient-centric care delivery, attracted by its expanding indications and adaptability in evolving care models.

Market Snapshot: Photopheresis Product Market Size and Growth

The global photopheresis product market grew from USD 552.19 million in 2024 to USD 596.80 million in 2025 and is projected to reach USD 1.03 billion by 2032, driven by a CAGR of 8.13%. This expansion reflects increasing clinical adoption for diverse conditions, supported by innovation in device technology and evolving reimbursement systems. Multiple regions are witnessing steady acceleration, as manufacturers and healthcare providers adapt to broadened medical indications and updated care protocols.

Scope & Segmentation

This report delivers a comprehensive examination of the photopheresis sector, offering actionable insights for stakeholders on changing market dynamics and strategic segment opportunities. The analysis details key segmentations that capture current trends and support informed decision-making:

• Mode: Centrifugation Based; Filtration Based – Both facilitate the separation essential to effective photopheresis procedures and impact throughput and operational efficiency in different care settings.
• Technology: Inline Integrated System; Offline Parallel System – Technology choices influence installation complexity, workflow integration, and ease of use, affecting adoption rates among institutions.
• Distribution Channel: Direct; Indirect – Direct distribution enhances manufacturer-provider collaboration, while indirect channels expand reach, particularly in emerging markets.
• End User: Ambulatory Surgical Centers; Blood Centers; Hospitals; Specialty Clinics – Diverse end users underscore the therapy’s flexibility and evolving role in outpatient and specialty environments.
• Application: Cutaneous T Cell Lymphoma; Graft Versus Host Disease; Organ Transplant Rejection – The spectrum of clinical applications demonstrates photopheresis’ shifting role in immune modulation and chronic disease management.
• Region: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru); Europe; Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan) – Regional segmentation highlights differences in regulatory maturity, adoption rates, and collaboration networks.
• Companies: Mallinckrodt Pharmaceuticals plc; Macopharma S.A.S.; Terumo BCT, Inc.; Miltenyi Biotec GmbH; Fresenius SE & Co. KGaA; PIT Medical Systems; Haemonetics Corporation; Therakos LLC – A dynamic competitive landscape with both established and emerging players.

Photopheresis Product Market: Key Takeaways

• Clinical use has expanded significantly, moving beyond cutaneous T cell lymphoma to support diverse transplant and autoimmune disorder treatments in multiple healthcare environments.
• Innovative device designs now emphasize modularity and real-time data monitoring, streamlining clinical workflows and supporting greater procedural efficiency for providers.
• Collaborative partnerships between device manufacturers, academic centers, and clinical networks are intensifying, resulting in more robust clinical validation and data-driven adoption.
• The transition toward decentralized and point-of-care models is reducing dependence on centralized hospital settings and improving access, particularly in rural and community-based care.
• Regional market variations—influenced by regulatory frameworks, reimbursement processes, and the presence of professional societies—are shaping unique adoption pathways and facilitating the transfer of best practices.
• Strong competition between established medical technology providers and agile newcomers is stimulating improvements in affordability, digital integration, and after-sales support, helping stakeholders to achieve operational targets more efficiently.

Tariff Impact: United States, 2025

Recent tariff adjustments on photopheresis instruments and disposables in the United States have prompted manufacturers to adjust sourcing and distribution models. Many are shifting toward regional or localized production, which is increasing the focus on supply chain partnerships and flexible pricing. Manufacturers and service providers are working with policymakers to balance technology waivers with incentives for domestic manufacturing, aiming to maintain market accessibility while safeguarding profitability.

Methodology & Data Sources

This research leverages extensive interviews with clinicians, manufacturers, and regulatory stakeholders, underpinned by systematic reviews of peer-reviewed literature, technical documents, and patent filings. Quantitative assessments of supply chains and regional regulation are validated by field experts, ensuring relevance and accuracy of the market findings.

Why This Report Matters

• Enables leadership teams to plan the integration of photopheresis into care and operational models with greater accuracy and foresight.
• Supports vendors and buyers in understanding the evolving competitive landscape and identifying optimal partnership, investment, and expansion strategies that align with market realities.
• Equips stakeholders to proactively manage regulatory, tariff, and supply chain challenges, ultimately reducing risk and supporting sustainable growth.

Conclusion

Photopheresis is poised for further growth as new use cases and improved technologies shape care strategies. Stakeholders who align with sector shifts will capture expanded opportunities as the market continues to evolve.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.